Gold vs US Dollar

Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Pliant Therapeutics Inc (PLRX)
Pliant Therapeutics Inc (PLRX) Financials

PLRX Pliant Therapeutics Inc

12.98

0.00 (0.00%)

Pre Market

Last Updated: 09:00:00

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-105.674	-7.388	-20.036	-37.645	-43.132	-37.4
Return on Equity (%)	98.37	9.28	-40.174	-40.348	-48.135	-41.005
Return on Invested Capital (%)	-102.882	-1.474	-21.384	-40.569	-48.82	-45.771
Operating Margin (%)	N/A	-1.106	-99.321	-1284.509	-1265.152	-10130.949
Net Profit Margin (%)	N/A	-12.017	-99.321	-1284.509	-1273.32	-10211.139
Book Value Per Share	6.222	8.332	7.962	5.517	6.402	7.907
Earnings Per Share	-3.607	-0.519	-1.168	-2.696	-2.52	-2.694
Cash Per Share	6.254	6.501	1.431	1.432	0.688	1.056
Working Capital Per Share	5.813	7.859	7.852	5.338	6.465	7.963
Operating Profit Per Share	N/A	4.322	1.176	0.21	0.198	0.026
EBIT Per Share	-3.107	-0.048	-1.168	-2.696	-2.52	-2.694
EBITDA Per Share	-3.107	-0.048	-1.168	-2.696	-2.52	-2.694
Free Cash Flow Per Share	-3.437	-0.531	-1.162	-2.684	-2.521	-2.709

Liquidity Ratios

Year End 31 December 2023	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	9.75M	13.2M	35.55M	36.08M	48.94M	N/A

Key Stats and Ratios

Year End 31 December 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	48.75M	48.94M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	-2795.571	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	-2818.919	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	789.88M
Price to Earnings Ratio	-4.9
Price to Sales Ratio	499.23
Price to Cash Ratio	12.49
Price to Book Ratio	1.67
Dividend Yield	-

Share Statistics

Shares Outstanding	60.85M
Average Volume (1 week)	739.6k
Average Volume (1 Month)	487.61k
52 Week Change	-9.04%
52 Week High	19.62
52 Week Low	10.22

More Ratios Coming Soon!

Pliant Therapeutics

New Oriental Education &...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions